Physicians offer new procedure to manage fecal incontinence, an underreported and debilitating condition

September 27, 2012

Fecal incontinence, or the inability to control the bowels, is a highly underreported and stigmatized condition, according to colorectal surgeons at Loyola University Health System (LUHS).

"This is a debilitating condition, which drastically affects a person's quality of life," said Dana Hayden, MD, MPH, colorectal surgeon, LUHS. "People with fecal incontinence avoid leaving the house to prevent an embarrassing accident from happening in public."

Fecal incontinence is more common in older adults, and although it affects women more commonly, men can also suffer from this disorder. This condition can be caused by a variety of factors, including damage to the pelvic nerves or muscles from trauma such as childbirth, and anal or rectal surgery; diseases like diabetes; or complications from radiation. The National Institutes of Health (NIH) estimates that more than 18 million Americans have fecal incontinence, yet Loyola doctors believe it is much higher.

"Fecal incontinence isn't something that people talk about, yet we know from our practice that it is extremely common," said Dr. Hayden, who also is an assistant professor in the Division of Colorectal Surgery at Loyola University Chicago Stritch School of Medicine. "The good news is there are options to manage this condition."

Loyola now offers a new procedure for patients with fecal incontinence called sacral nerve stimulation. The U.S. recently approved this minimally for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments. This procedure also has been used for years at Loyola in patients with urinary urge incontinence.

The technology uses an implantable apparatus, consisting of a thin wire and a neurostimulator, or pacemakerlike device, to stimulate the nerves that control bowel function. This technology uses an external during a trial assessment period. If the device is effective, physicians implant a device that can be used indefinitely. This procedure is done in an outpatient setting under mild sedation. Patients return home the same day with minimal discomfort.

"Studies have shown that sacral nerve stimulation reduces incontinent episodes and increases quality of life in a majority of patients with chronic ," Dr. Hayden said. "These are dramatic, long-term results for patients who are dealing with chronic bowel control issues."

Explore further: New therapy provides hope for millions of people suffering from bowel incontinence

Related Stories

New therapy provides hope for millions of people suffering from bowel incontinence

July 18, 2011
A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim Therapy is a minimally invasive procedure ...

Caring for patients with fecal incontinence costs more than $4,000 per person each year

May 31, 2012
Care for patients with fecal incontinence costs $4,110 per person for both medical and non-medical costs like loss of productivity, according to new research from the University of Michigan.

URMC surgeon is nation's first to implant pacemaker-like device for bowel incontinence

July 4, 2011
(Medical Xpress) -- Since the technology secured FDA approval this spring, a University of Rochester Medical Center (URMC) surgeon this month became the first in the nation to implant a pacemaker-like device that could help ...

Nerve stimulation procedure can improve bowel control problems

October 21, 2011
An estimated 18 million adults suffer silently with a life-altering condition, known as bowel incontinence, because they believe the problem can’t be fixed.

Botox now used for urinary incontinence

March 14, 2012
When you think of Botox injections, you probably think of getting rid of unwanted wrinkles around the eyes or forehead, but recently the U.S. Food and Drug Administration (FDA) approved using the injections to help patients ...

Recommended for you

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

Fatty liver can cause damage to other organs via crosstalk

August 21, 2017
Nonalcoholic fatty liver disease is increasingly common. Approximately every third adult in industrialized countries has a morbidly fatty liver. This not only increases the risk of chronic liver diseases such as liver cirrhosis ...

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.